Latest news
Aclaris Therapeutics (ACRS) Stock Drifts Lower As Losses Deepen On Thin Revenue - simplywall.stsimplywall.st · Fri, 07 Aug 2026 22:30:43 GMTAclaris Therapeutics, Inc. (ACRS) Stock Price, News, Quote & History - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 20:20:28 GMTUS FDA Fast-tracks Aclaris’ Modzatinib for Lichen Planus - The Dermatology DigestThe Dermatology Digest · Fri, 07 Aug 2026 15:34:47 GMTAclaris Therapeutics, Inc. (ACRS) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Fri, 07 Aug 2026 13:08:53 GMTCraig-Hallum Maintains Aclaris Therapeutics(ACRS.US) With Buy Rating, Maintains Target Price $10 - MoomooMoomoo · Fri, 07 Aug 2026 07:54:52 GMTAclaris Therapeutics (ACRS) Releases Q2 2026 Earnings: Revenue Declines, Losses Narrow - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 21:10:00 GMTAclaris Therapeutics Receives Fast Track Designation for - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:35:00 GMTAclaris Therapeutics (ACRS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:20:02 GMT